2+ hour, 15+ min ago   (314+ words) Deal-making news last week including Spanish dermatology specialist Almirall entering into a research collaboration with China’s CrystalO Biopharma. Sentynl entered a deal to license lung disease candidate alvelestat from Mereo BioPharma, which could earn the latter nearly half a billion…...

1+ day, 23+ hour ago   (301+ words) The Pharma Letter - Russia faces serious decline in launches of new cancer drugs this year The number of new cancer drugs are being launched in the Russian market is steadily declining these days, which is mainly due to the drop…...

4+ day, 4+ hour ago   (180+ words) Avere Therapeutics is headquartered in San Francisco, California. The company operates as a focused, clinical-stage enterprise with no additional sites disclosed at this time. AVR-001 is the company's sole disclosed program and its entire clinical thesis. It is an oral…...

5+ day, 3+ hour ago   (228+ words) The Pharma Letter BMS investing $2.3 billion in Texas campus Bristol Myers Squibb (NYSE: BMY) has announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the…...

5+ day, 4+ hour ago   (216+ words) The Pharma Letter - Former World Bank president joins ImmunityBio exec team US immunotherapy company ImmunityBio (Nasdaq: IBRX) has announced that Dr Jim Yong Kim has joined the company as vice chairman. Dr Kim will serve in a newly created Office…...

5+ day, 21+ hour ago   (252+ words) The Pharma Letter - Jazz expands epilepsy portfolio with buy of Actio Biosciences Ireland-headquartered Jazz Pharmaceuticals (Nasdaq: JAZZ) has entered into a definitive agreement to acquire privately-held US biotech Actio Biosciences with the aim of expanding its epilepsy portfolio. Actio Biosciences…...

1+ week, 1+ day ago   (222+ words) The Pharma Letter China approval for TransThera’s Yochanra Chinese biopharma TransThera Sciences' Yochanra (tinengotinib) has been approved in China for adults with advanced, metastatic or unresectable cholangiocarcinoma harboring a fibroblast growth factor receptor2 (FGFR2) fusion or rearrangement who have previously received systemic…...

1+ week, 2+ day ago   (206+ words) The Pharma Letter - Mediar Therapeutics enters option deal with Ono Pharma US fibrosis-focused drug developer Mediar Therapeutics has entered into a collaboration and option agreement with Japan’s Ono Pharmaceutical (TYO: 4528) for novel treatments targeting fibro-inflammatory diseases. These diseases are characterized…...

1+ week, 2+ day ago   (217+ words) The Pharma Letter - India strengthens regional health diplomacy with BCG vaccine support India dispatched 13 tonnes of BCG vaccines to Afghanistan last month to bolster its child immunization drive. The move underscores India’s role as a regional health partner, extending support…...

1+ week, 2+ day ago   (261+ words) thepharmaletter.com - Marengo Tx appoints Saso Cemerski as head of immunology Cambridge, USA-based clinical-stage biotech Marengo Therapeutics has announced two important milestones reflecting the advancement of its TriSTAR platform: the appointment of Saso Cemerski as senior vice president, head of…...